Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-25-005067

CHIEF EXECUTIVE OFFICER sold 2,159 shares at $1.15 ($2,483)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lettmann Jason CHIEF EXECUTIVE OFFICER 2025-02-19 Sale −2,159 $1.15 $2,483 170,270 D
Open-market sales · 2,159 sh · avg $1.15 · $2,483
Loading xslF345X05/form4-02212025_090215.xml…